Cuba is currently working on a specific vaccine to fight the new COVID-19 variant named Omicron, said the President of the Cuban Biotech Conglomerate BioCubaFarma, Eduardo Martinez.
Health workers, students of Medical Sciences and other risk groups, including those from the Tourism sector, the Ministry of the Interior and Transportation in the province of Holguín began to receive single anti-COVID booster doses of Abdala, with the aim of maintaining immunity against the lethal disease.
Cuban researchers highlighted the positive results of the national anti-Covid-19 vaccines as booster of other formulations, on the occasion of the beginning today of the administration of Soberana Plus to health personnel.
Holguín shows a better epidemiological scenario; however, this is the province with the highest report of cases confirmed in the country and the one that contributes the highest number of deaths, with a fatality rate above one percent.
The development of a novel formulation of recombinant human erythropoietin (NeuroEpo) by the Center for Molecular Immunology, in collaboration with others, offers hope in the treatment of this devastating illness.